() chief executive James Barder caught up with Proactive London's Andrew Scott to talk through the firm's interim results.
He says the company’s team is speaking to key opinion leaders in the field of erectile dysfunction ahead of publishing headline data on lead erectile dysfunction drug MED 2005 later this year.
It's a fast-acting gel that eliminates some of the common side-effects of the current pill-based treatments.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Futura Medical PLC named herein, including the promotion by the Company of Futura Medical PLC in any Content on the Site, the Company receives...
FOR OUR FULL DISCLAIMER CLICK HERE